Biocon India, located in Bangalore, is a pioneering biotechnology
company engaged
in the manufacture of speciality industrial enzymes and active
pharmaceutical ingredients. Syngene International, Biocon's
associate group company, carry out drug-based contract research
and informatics-based software development for the Pharmaceutical
industry. The two companies have brought together their expertise
in the field of biotechnology to form The Biocon India group.
Biocon India, the first enzyme company to be accredited with
ISO 9001 certification in 1993, produces and markets a wide
range of high-quality food and industrial enzymes, ingredients
and process aids and is positioned to become the undisputed
market leader in industrial enzymes, particularly those used
in brewing and textiles.
Biocon India has the logo statement 'Working with nature'
and the emphasis here is on quality, safety and the environment.
The company's clientele spans a diverse range of industry segments
from brewing, food and beverages, animal feed and starch processing
to textiles, paper and pulp, detergents, leather and pharmaceuticals.
Biocon India's R & D base has developed a number of innovative
technologies. It boasts of having filed its first US patent
in November 1998 for a novel Bioreactor based on solid substrate
technology.
Person behind Biocon India:
Kiran Mazumdar heads Biocon India as its Chairman
and Managing Director. On account of her knowledge of
the business community in Bangalore, the Ireland Ambassador
Philip D Mc Donagh has appointed her as an Honorary Consul for
Ireland in Bangalore in November 2000. As an Honorary Consul,
she will provide consular services to Irish citizens, residents,
or those visiting Karnataka, assist the embassy in New Delhi
in promoting economical relations between Ireland and India.
She also heads the Karnataka's task force on Biotechnology.
About Biocon's service coverage: The Company services
the cardio-vascular, anti-inflammatory, gynecology and hepato-protective
segments. It manufactures a wide range of fermentation and synthetic
chemistry products, as well as biological extracts. Statins,
the first products to be commercialised, are by far considered
the most effective drugs for cholesterol control.
Company's strengths: Biocon India's strength has been
in creating niche markets through innovative products and product
applications via its expertise and by having strategic alliances
with several international players like Genencor International
(one of the largest enzyme producers) and Quest International,
Holland for food enzymes.
The company continually seeks ways to make research more focused
and useful for its customers. By providing them with cleaner,
safer and more efficient solutions, it has created a niche in
making its client's business more productive.
For more details:
Biocon India Limited, 20th K M, Hosur Road, Hebbagodi, Bangalore--
561229 Dr Nirupa Bareja, Group Head, HR,
E-mail:nirupabareja@bioconindia.com
12:35:54 AM 
in the manufacture of speciality industrial enzymes and active
pharmaceutical ingredients. Syngene International, Biocon's
associate group company, carry out drug-based contract research
and informatics-based software development for the Pharmaceutical
industry. The two companies have brought together their expertise
in the field of biotechnology to form The Biocon India group.
